European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F15%3A43910354" target="_blank" >RIV/00216208:11120/15:43910354 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064173:_____/15:#0000499

Výsledek na webu

<a href="http://dx.doi.org/10.1111/jdv.13354" target="_blank" >http://dx.doi.org/10.1111/jdv.13354</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1111/jdv.13354" target="_blank" >10.1111/jdv.13354</a>

Jazyk výsledku

angličtina

Název v původním jazyce

European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC

Popis výsledku v původním jazyce

This is an executive summary of all consented recommendations of the European Psoriasis Guidelines - Update 2015. The long version of this guideline is available online as supplementary file. A detailed description of the used methodology can be found inthe methods report (DOI: 10.1111/jdv.13353). In brief, available evidence of the efficacy and safety of the systemic treatments for psoriasis including an assessment of the quality of evidence was summarized using GRADE (Grading of Recommendations Assessment, Development and Evaluation).1 The end of the literature search was October 12th, 2014. Some parts of the guidelines are based on a complete literature review (marked as evidence based), other parts are based on expert consensus only (marked as expert opinion). All recommendations (highlighted in grey) were formulated and consented by an expert panel, officially nominated by the European Dermatology Forum (EDF), the European Association for Dermatology and Venereology (EADV) or the

Název v anglickém jazyce

European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC

Popis výsledku anglicky

This is an executive summary of all consented recommendations of the European Psoriasis Guidelines - Update 2015. The long version of this guideline is available online as supplementary file. A detailed description of the used methodology can be found inthe methods report (DOI: 10.1111/jdv.13353). In brief, available evidence of the efficacy and safety of the systemic treatments for psoriasis including an assessment of the quality of evidence was summarized using GRADE (Grading of Recommendations Assessment, Development and Evaluation).1 The end of the literature search was October 12th, 2014. Some parts of the guidelines are based on a complete literature review (marked as evidence based), other parts are based on expert consensus only (marked as expert opinion). All recommendations (highlighted in grey) were formulated and consented by an expert panel, officially nominated by the European Dermatology Forum (EDF), the European Association for Dermatology and Venereology (EADV) or the

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FO - Dermatovenerologie

OECD FORD obor

—

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of the European Academy of Dermatology and Venereology

ISSN

0926-9959

e-ISSN

—

Svazek periodika

29

Číslo periodika v rámci svazku

12

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

18

Strana od-do

2277-2294

Kód UT WoS článku

000367682300002

EID výsledku v databázi Scopus

—